Where to Position Clozapine: Re-Examining the Evidence

Antipsychotic Use in the Treatment of Outpatients With Schizophrenia in the VA From Fiscal Years 1999 to 2006

(2014) Michael J. Sernyak et al.   PSYCHIATRIC SERVICES

Utilization and Costs of Antipsychotic Agents: A Canadian Population-Based Study, 1996–2006

(2014) Silvia Alessi-Severini et al.   PSYCHIATRIC SERVICES

Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial

(2014) Marvin S. Swartz et al.   PSYCHIATRIC SERVICES

Predictors of long-term outcome in schizophrenia

(2009) Robin Emsley et al.   CURRENT OPINION IN PSYCHIATRY

Treating Movement Disorders and Akathisia as Side Effects of Antipsychotic Pharmacotherapy

(2009) Peter F. Buckley   JOURNAL OF CLINICAL PSYCHIATRY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

(2009) Gerhard Gründer et al.   NATURE REVIEWS DRUG DISCOVERY

Treatment Pathway and Patterns of Clozapine Prescribing for Schizophrenia in New Zealand

(2008) Amanda J Wheeler   ANNALS OF PHARMACOTHERAPY

Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data

(2008) Chao-Cheng Lin et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Clozapine-induced agranulocytosis and its genetic determinants

(2008) Carolin Opgen-Rhein et al.   PHARMACOGENOMICS

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

(2008) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Results of phase 3 of the CATIE schizophrenia trial

(2008) T. Scott Stroup et al.   SCHIZOPHRENIA RESEARCH